Synthetic Biologics, Inc. (SYN)
Total Liabilities
$22.67M
Quarterly · Period ending: · USD

SYN Total Liabilities
Latest reported$22.67Mperiod ending
Latest reported$22.67Mperiod ending
SYN Quarterly Total Liabilities ($900.00K → $22.67M)
Quarterly total liabilities
High-resolution chart · PNG
SYN total liabilities history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Liabilities (USD) |
|---|---|
| 22,670,000 | |
| 22,849,000 | |
| 22,856,000 | |
| 24,098,000 | |
| 25,207,000 | |
| 16,664,000 | |
| 16,285,000 | |
| 14,744,000 | |
| 17,661,000 | |
| 17,696,000 | |
| 17,300,000 | |
| 17,297,000 | |
| 20,546,000 | |
| 20,657,000 | |
| 20,972,000 | |
| 4,957,000 | |
| 4,561,000 | |
| 3,524,000 | |
| 2,230,000 | |
| 3,152,000 | |
| 3,271,000 | |
| 3,763,000 | |
| 3,281,000 | |
| 5,748,000 | |
| 6,172,000 | |
| 4,412,000 | |
| 3,624,000 | |
| 3,686,000 | |
| 4,243,000 | |
| 4,672,000 | |
| 5,464,000 | |
| 22,248,000 | |
| 29,943,000 | |
| 12,778,000 | |
| 16,958,000 | |
| 20,249,000 | |
| 14,224,000 | |
| 15,400,000 | |
| 17,766,000 | |
| 15,842,000 | |
| 17,499,000 | |
| 25,498,000 | |
| 15,341,000 | |
| 9,588,000 | |
| 984,000 | |
| 1,232,000 | |
| 773,000 | |
| 1,027,000 | |
| 584,000 | |
| 229,000 | |
| 196,000 | |
| 395,000 | |
| 417,000 | |
| 395,000 | |
| 443,000 | |
| 417,000 | |
| 236,362 | |
| 400,213 | |
| 1,200,127 | |
| 532,484 | |
| 441,086 | |
| 686,354 | |
| 501,153 | |
| 531,431 | |
| 449,072 | |
| 574,404 | |
| 784,430 | |
| 620,716 | |
| 677,036 | |
| 816,198 | |
| 1,317,532 | |
| 1,687,528 | |
| 1,759,646 | |
| 1,631,690 | |
| 1,141,943 | |
| 729,019 | |
| 3,017 | |
| 9,350 | |
| 2,143,758 | |
| 11,877,713 | |
| 17,487,166 | |
| 16,900,642 | |
| 16,182,784 | |
| 15,399,594 | |
| 13,307,431 | |
| 11,142,554 | |
| 8,751,802 | |
| 6,327,105 | |
| 5,525,075 | |
| 5,864,377 | |
| 4,162,112 | |
| 4,140,614 | |
| 4,148,795 | |
| 4,377,582 | |
| 4,800,000 | |
| 3,500,000 | |
| 2,800,000 | |
| 2,200,000 | |
| 1,500,000 | |
| 1,200,000 |